#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunoglobulin G4 related disease Colorectal cancer metastatic Angelman's syndrome Marginal zone lymphoma recurrent Neuroblastoma Oropharyngeal cancer recurrent Small intestine adenocarcinoma Growth hormone deficiency Ovarian cancer stage IV Chronic graft versus host disease in skin Hereditary angioedema Angiosarcoma recurrent Round cell liposarcoma Cholangiocarcinoma Metastases to peritoneum More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive – Life with Disease Mucopolysaccharidosis II Progressive supranuclear palsy – Diagnostics X-linked lymphoproliferative syndrome – Life with Disease Mantle cell lymphoma stage III – Life with Disease Progressive multifocal leukoencephalopathy – Life with Disease Vascular malformation Hepatoblastoma – Basic Information Mitochondrial myopathy – Diagnostics Congenital nephrogenic diabetes insipidus – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zinc Acexamate Bi 764524 Treprostinil Censavudine Aripiprazole ANXV Istem-01 AMG 732 Tramadol Hydrochloride Gozetotide Alf-18 Rebisufligene Etisparvovec Cetirizine Sodium Phosphate Sufentanil Citrate Sargramostim Doxycycline Monohydrate Imifoplatin Desflurane Fludarabine Phosphate Atomoxetine Hydrochloride More therapies…

    Learn about Your Condition

    Infertility Osteomyelitis acute Retinopathy proliferative Nicotine dependence Pulmonary hypertension Breast cancer stage IV Hypogonadism male Hepatitis alcoholic Lichenoid keratosis Renal impairment Laparoscopic surgery Cartilage injury Breast cancer stage II Varicella Adenocarcinoma pancreas More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Gornoslaskie Centrum Mwdyczne

Gornoslaskie Centrum Mwdyczne

Ul. Ziolowa 45/47, Katowice, 40-635, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke

    Recruiting

    4 1
    Investigated Drugs:
    • JX10
    Belgium Bulgaria Finland France Germany Greece +7

  • Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ferric Derisomaltose
    Bulgaria Croatia Czechia Denmark Hungary Latvia +6

  • Long-Term Safety Study of Inhaled Pirfenidone for Patients with Progressive or Idiopathic Pulmonary Fibrosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pulmonary fibrosis
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Pirfenidone
    Czechia France Germany Italy The Netherlands Poland +1

  • Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial flutter
    • Chronic coronary syndrome
    • Acute coronary syndrome
    Investigated Drugs:
    • Dabigatran
    • Apixaban
    • Edoxaban
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on Valsartan and Sacubitril for Preventing Disease Progression in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Sacubitril
    • Valsartan
    Poland

  • Long-term Safety Study of Tadalafil and Macitentan for Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Macitentan
    • Selexipag
    • Tadalafil
    Bulgaria France Hungary Poland

  • Study on Colchicine for Preventing Artery Narrowing in Patients with Lower Extremity Artery Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Colchicine
    Poland

  • Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Austria Bulgaria Czechia France Germany Greece +8

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

    Not yet recruiting

    4 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Austria Belgium Czechia Denmark France Germany +9
Previous Page
1 2 3 4 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!